Verified· 2 sources

Elthera AG

Summary

About the company

The core activity of Elthera AG is the development of precision medicine oncology solutions, particularly the research and development of L1CAM-based immunotherapies to combat aggressive tumors.

AI-generated

Offering

Products & services

Industry:Pharmaceutical Industry

✓ Offered3

Development of L1CAM antibody therapies

Development of antibodies against L1CAM for the treatment of aggressive tumors; targeted immunotherapy for the active elimination of cancer cells and halting tumor progression.

Personalized oncology drug development

Development of proprietary First-in-class oncology drugs with a personalized approach; combination of targeted therapy and companion diagnostics for patients with aggressive malignancies.

Partnering and licensing

Partnering with investors and collaborators; collaborations to develop anti-L1CAM therapies, companion diagnostics and liquid biopsy methods, including licensing of IP rights.

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Elthera AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

Elthera AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

Elthera AG in comparison

Industry comparisons are coming soon

Similar companies